Skip to main content

Advertisement

SpringerLink
Log in

Knowledge, attitudes, and practices of community pharmacists on generic medicines in Qatar

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background The practice of generic medicines prescribing, dispensing and substitution in developing countries has been controversial among healthcare professionals, particularly due to issues on quality, safety and efficacy. These controversies are as a result of inter-country differences in policies and laws as well as individualized knowledge and attitudes of pharmacists pertaining to generic medicines. Objective This study primarily aims to assess the knowledge, attitudes, and practices of community pharmacists in Qatar towards generic medicines. Setting Community pharmacy settings throughout the State of Qatar. Method A cross-sectional study using a pretested paper-based survey was conducted among a random sample of community pharmacists in Qatar. The data were analyzed using IBM-SPSS® version 20. Both descriptive and inferential statistical analyses were applied. Main outcome measure Knowledge, attitudes, and practices of generic medicines pertaining to regulatory standards, safety, efficacy, quality, and future policies. Results A total of 160 surveys were distributed to community pharmacists of which 118 were returned (response rate, 74 %). The mean total score of generic medicines knowledge among the pharmacists was 6.8 ± 1.6 (maximum possible score was 10). Years of practice as well as place of obtaining academic degree did not influence knowledge score. Approximately 72 % of the pharmacists supported generic substitution for brand name drugs in all cases where a generic medicine is available and the majority (93 %) agreed that pharmacists should be given generic substitution right. Nearly 61 % of the pharmacists considered lack of proven bioequivalence to original brands as an important barrier for selecting generic medicines and 55 % rated “lack of policy for directing the practice of generic medicine” as an important barrier. Conclusion In order to enhance the quality use of and to promote the practice of generic medicines in Qatar, an educational program should be implemented. A national generic medicine policy and guidelines are warranted in the State of Qatar.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cumming J, Mays N, Daubé J. How New Zealand has contained expenditure on drugs. BMJ. 2010;340:c2441

    Article  PubMed  Google Scholar 

  2. Tordoff JM, Norris PT, Reith DM. Managing prices for hospital pharmaceuticals: a successful strategy for New Zealand? Value Health. 2005;8(3):201–8

    Article  PubMed  Google Scholar 

  3. Tordoff JM, Norris PT, Reith DM. Price management and its impact on hospital pharmaceutical expenditure and the availability of medicines in New Zealand hospitals. Value Health. 2008;11(7):1214–26

    Article  PubMed  Google Scholar 

  4. Qatar Pharmaceuticals and Healthcare Report Q2 2010. [cited 2011 15 October]; http://www.marketresearch.com/product/display.asp?productid=2612820&SID=19250790-508361963-526992013

  5. Supreme Council of Health. [cited 2013 11 November]; http://www.sch.gov.qa/sch/En/scontent.jsp?smenuId=13&CSRT=9938509536596769030

  6. Hamad Medical Corporation. Healthcare in Qatar. [cited 2013 11 November]; http://www.hmc.org.qa/en/hcp/healthcare_in_qatar/healthcare_in_qatar.aspx

  7. National Health Strategy 2011–2016. Comprehensive world class healthcare system. [cited 2013 15 November]; http://www.nhsq.info/strategy-goals-and-projects/comprehensive-world-class-healthcare

  8. National Health Strategy 2011–2016. Comprehensive world class healthcare system: community pharmacies strategy [cited 2013 15 November]; http://www.nhsq.info/strategy-goals-and-projects/comprehensive-world-class-healthcare/community-pharmacies-strategy

  9. Adelman C, Norris J. Generic medicines are not substandard medicines. Lancet. 2002;359(9314):1351–2

    Article  Google Scholar 

  10. Canadian Generic Pharmaceutical Association. Matching US generic drug use would save Canada $1.6-Billion, Toronto, April 6, 2010. Toronto: Canadian Generic Pharmaceutical Association; [cited 2011 20 October]; http://www.canadiangenerics.ca/en/news/apr_06_10.asp

  11. Kanavos P. Do generics offer significant savings to the UK National Health Service? Curr Med Res Opin. 2007;23(1):105–16

    Article  PubMed  Google Scholar 

  12. Karim SA, Pillai G, Ziqubu-Page T, Cassimjee M, Morar M. Potential savings from generic prescribing and generic substitution in South Africa. Health Policy Plan. 1996;11(2):198–205

    Article  PubMed  CAS  Google Scholar 

  13. King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croat Med J. 2002;43(4):462–9

    PubMed  Google Scholar 

  14. Ford N, Hoen E. Generic medicines are not substandard medicines. Lancet. 2002;359(9314):1351

    Article  PubMed  Google Scholar 

  15. Perry G. The European generic pharmaceutical market in review: 2006 and beyond. J Generic Med. 2006;4(1):4–14

    Article  Google Scholar 

  16. Simoens S. Generic medicine pricing in Europe: current issues and future perspective. J Med Econ. 2008;11(1):171–5

    Article  PubMed  Google Scholar 

  17. Garattini L, Tediosi F. A comparative analysis of generics markets in five European countries. Health Policy. 2000;51(3):149–62

    Article  PubMed  CAS  Google Scholar 

  18. Birkett DJ. Generics-equal or not? Austr Prescriber. 2003;26(4):85–7

    Google Scholar 

  19. Hassali A, Stewart K, Kong D. Quality use of generic medicines. Austr Prescriber. 2004;27:80–1

    Google Scholar 

  20. Lamy PP. Generic equivalents: issues and concerns. J Clin Pharmacol. 1986;26(5):309–16

    Article  PubMed  CAS  Google Scholar 

  21. Babar Z-U-D, Grover P, Stewart J, Hogg M, Short L, Seo HG, et al. Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand. Res Soc Adm Pharm. 2011;7(3):294–305

    Article  Google Scholar 

  22. Campbell M, Bateman DN, Lee A, Smith J, Beaney A. The pros and cons of generic medicines. Pharmacoeconomics. 1995;8(4):362–3

    Article  PubMed  CAS  Google Scholar 

  23. Carroll NV, Wolfgang AP. Risks, benefits, and generic substitution. J Consum Aff. 1991;25(1):110–21

    Article  Google Scholar 

  24. Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther. 2003;25(11):2875–90

    Article  PubMed  Google Scholar 

  25. Barba Z-U-D, Awaisu A. Evaluating community pharmacists’ perceptions and practices on generic medicines: a pilot study from Peninsular Malaysia. J Generic Med. 2008;5(4):315–30

    Article  Google Scholar 

  26. Carroll NV, Siridhara C, Fincham JE. Perceived risks and pharmacists’ generic substitution behavior. J Consum Aff. 1986;20(1):36–47

    Article  Google Scholar 

  27. Carroll NV, Wolfgang AP. Inherent risk and market acceptance of generic drug products. J Health Care Mark. 1989;9(4):48–51

    PubMed  CAS  Google Scholar 

  28. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240–9

    Article  PubMed  CAS  Google Scholar 

  29. Cameron A, Mantel-Teeuwisse AK, Leufkens HGM, Laing RO. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved? Value Health. 2012;15(5):664–73

    Article  PubMed  Google Scholar 

  30. Kaplan WA, Ritz LS, Vitello M, Wirtz VJ. Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000–2010. Health Policy. 2012;106(3):211–24

    Article  PubMed  Google Scholar 

  31. Mott DA, Cline RR. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care. 2002;40(8):662–74

    Article  PubMed  Google Scholar 

  32. Jamshed SQ, Ibrahim MIM, Hassali MA, Babar ZUD, Alkalami R, Siddiqui MJ. Do hospital pharmacists in Pakistan understand the concept of generic medicines? a mixed-method approach. Res Soc Adm Pharm. 2012;8(6):e17

    Article  Google Scholar 

  33. Jamshed SQ, Ibrahim MIM, Hassali MA, Babar ZUD, Alkalami R, Siddiqui MJ. Do community pharmacists understand the concept of generic medicines? A quantitative insight from Karachi, Pakistan. Res Social Adm Pharm. 2012;8(6):e16–7

    Article  Google Scholar 

  34. Center for Drug Evaluation and Research FDA. Guidance for industry. Bioavailability and bioequivalence studies for orally administered drug products—general consideration. Rockville, MD: U.S. Department of Health and Human Services; 2003 [cited 2013 13 March]; http://www.fda.gov/downloads/Drugs/…/Guidances/ucm070124.pdf

  35. Al-Gedadi NA, Hassali MA. Pharmacists’ views on generic medicines: a review of the literature. J Generic Med. 2008;5(3):209–18

    Article  Google Scholar 

  36. Chong CP, Hassali MA, Bahari MB, Shafie AA. Evaluating community pharmacists’ perceptions of future generic substitution policy implementation: a national survey from Malaysia. Health Policy. 2010;94(1):68–75

    Article  PubMed  Google Scholar 

  37. Chong CP, Hassali MA, Bahari MB, Shafie AA. Exploring community pharmacists’ views on generic medicines: a nationwide study from Malaysia. Int J Clin Pharm. 2011;33(1):124–31

    Article  PubMed  Google Scholar 

  38. Chong CP, Hassali MA, Bahari MB, Shafie AA. Generic medicine substitution practices among community pharmacists: a nationwide study from Malaysia. J Public Health. 2011;19(1):81–90

    Article  Google Scholar 

  39. Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A web-based survey on Australian community pharmacists’ perceptions and practices of generic substitution. J Generic Med. 2010;7(4):342–53

    Article  Google Scholar 

  40. Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy. 2011;99(2):139–48

    Article  PubMed  Google Scholar 

  41. Hassali M, Kong D, Stewart K. Generic medicines: perceptions of community pharmacists in Melbourne, Australia. J Pharm Financ Econ Pol. 2005;14(3):27

    Article  Google Scholar 

  42. Bearden WO, Mason JB. Physician and pharmacist perceptions of generic drugs. Ind Mark Manag. 1979;8(1):63–8

    Article  Google Scholar 

  43. Granlund D. Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals? Soc Sci Med. 2009;69(11):1643–50

    Article  PubMed  Google Scholar 

  44. Paraponaris A, Verger P, Desquins B, Villani P, Bouvenot G, Rochaix L, et al. Delivering generics without regulatory incentives?: Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names. Health Policy. 2004;70(1):23–32

    Article  PubMed  CAS  Google Scholar 

  45. Crawford P, Feely M, Guberman A, Kramer G. Are there potential problems with generic substitution of antiepileptic drugs? A review of issues. Seizure. 2006;15(3):165–76

    Article  PubMed  CAS  Google Scholar 

  46. Borgheini G. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugs. Clin Ther. 2003;25(6):1578–92

    Article  PubMed  Google Scholar 

  47. Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease. JAMA. 2008;300(21):2514–26

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  48. Andersson K, Sonesson C, Petzold M, Carlsten A, Lönnroth K. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiol Drug Saf. 2005;14(5):341–8

    Article  PubMed  Google Scholar 

  49. Allenet B, Barry H. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharm World Sci. 2003;25(5):197–202

    Article  PubMed  Google Scholar 

  50. Vallès J-A, Barreiro M, Cereza G, Ferro J–J, Martınez MJ, et al. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy. 2003;65(3):269–75

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank all community pharmacists who voluntarily participated in this study.

Funding

This publication was made possible by a UREP award [UREP11-068-3-012] from the Qatar National Research Fund (a member of The Qatar Foundation).

Conflicts of interest

Statements made in this article are the sole responsibility of the authors. There are not other conflicts of interest.

Author information

Authors and Affiliations

  1. College of Pharmacy, Qatar University, P.O. Box 2713, Doha, Qatar

    Ahmed Awaisu, Nadir Kheir, Mohamed Izham Mohamed Ibrahim, Maguy El-Hajj, Huda Hazi, Nada Khudair & Raja Barazi

  2. Clinical Pharmacy and Practice Section, College of Pharmacy, Qatar University, P.O. Box 2713, Doha, Qatar

    Ahmed Awaisu, Nadir Kheir, Mohamed Izham Mohamed Ibrahim & Maguy El-Hajj

Authors
  1. Ahmed Awaisu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nadir Kheir
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohamed Izham Mohamed Ibrahim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maguy El-Hajj
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Huda Hazi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nada Khudair
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Raja Barazi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmed Awaisu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Awaisu, A., Kheir, N., Ibrahim, M.I.M. et al. Knowledge, attitudes, and practices of community pharmacists on generic medicines in Qatar. Int J Clin Pharm 36, 394–404 (2014). https://doi.org/10.1007/s11096-013-9909-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-013-9909-2

Keywords

Search

Navigation